- Home
- ANEB vs NOTV Comparison
ANEB vs NOTV Comparison
Compare ANEB & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- NOTV
- Stock Information
- Founded
- ANEB 2020
- NOTV 1974
- Country
- ANEB United States
- NOTV United States
- Employees
- ANEB N/A
- NOTV N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- NOTV Health Care
- Exchange
- ANEB Nasdaq
- NOTV Nasdaq
- Market Cap
- ANEB 79.9M
- NOTV 40.4M
- IPO Year
- ANEB 2021
- NOTV 1997
- Fundamental
- Price
- ANEB $1.83
- NOTV $1.69
- Analyst Decision
- ANEB Buy
- NOTV Strong Buy
- Analyst Count
- ANEB 1
- NOTV 3
- Target Price
- ANEB $8.00
- NOTV $5.92
- AVG Volume (30 Days)
- ANEB 17.2K
- NOTV 124.5K
- Earning Date
- ANEB 11-12-2024
- NOTV 12-09-2024
- Dividend Yield
- ANEB N/A
- NOTV N/A
- EPS Growth
- ANEB N/A
- NOTV N/A
- EPS
- ANEB N/A
- NOTV N/A
- Revenue
- ANEB N/A
- NOTV $501,062,000.00
- Revenue This Year
- ANEB N/A
- NOTV N/A
- Revenue Next Year
- ANEB N/A
- NOTV $8.69
- P/E Ratio
- ANEB N/A
- NOTV N/A
- Revenue Growth
- ANEB N/A
- NOTV N/A
- 52 Week Low
- ANEB $1.72
- NOTV $1.23
- 52 Week High
- ANEB $3.30
- NOTV $11.42
- Technical
- Relative Strength Index (RSI)
- ANEB 45.14
- NOTV 48.47
- Support Level
- ANEB $1.83
- NOTV $1.67
- Resistance Level
- ANEB $1.90
- NOTV $1.86
- Average True Range (ATR)
- ANEB 0.11
- NOTV 0.13
- MACD
- ANEB -0.01
- NOTV -0.02
- Stochastic Oscillator
- ANEB 3.12
- NOTV 16.22
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.